TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Minimum diameter of internal jugular vein (Dmin) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ventilator-free days at 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Children's Hospital of Eastern Ontario Pain Scale (CHEOPS) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pediatric anesthesia emergence delirium (PAED) scale change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in objective olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multimodal brain MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cure rate (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of Quantitative Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of Stability of operative level(s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum Trough Levels of Total IgG Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in gastrointestinal transit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in Modified Ashworth Scale (MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in Functional Independence measure (FIM) for the speech
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clearance of hr-HPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of overt gastrointestinal bleeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: International Cooperative Ataxia Rating Scale Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CASA-Q Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oocyst Prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AUCt (Area under the concentration time curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t½ (Apparent terminal elimination half-life)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Value of Neutralizing Antibody Against COVID-19 Variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Fold Rise of Neutralizing Antibody Against COVID-19 Variants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean diurnal IOP at Day 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean diurnal IOP at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Survival or mortality
Endpoint domain: Mortality/survival
Primary endpoint: Diet satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in body composition after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in systemic inflammation after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in insulin resistance after 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to study intervention
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Adherence to usual care
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of endophthalmitis after cataract surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Bone loss measured by CBCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Microbiological culture (bacterial cell count)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement of fibrosis stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Incidence, duration, and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Progression-free survival (PFS) by BICR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery at postoperative second day
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in muscle strength of knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in strength/endurance by 1-minute sit-up test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in muscle strength by handgrip test using hand dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in the muscular resistance of the trunk extensors by the Sorensen test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in cerebral hemodynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in functional ability of the upper extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motor function of the upper limbs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optoacoustic Absorption Spectrum of Muscle and Liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clients' knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Birth satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of people with an Adverse Event Assessment
Endpoint domain: Adverse events/effects
Primary endpoint: Number of people with abnormal laboratory test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of people with abnormal Electrocardiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of people with abnormal physical examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wisconsin gait scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke specific quality of life scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cardiac Anxiety Questionnaire (CAQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants recruited into study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CT or MRI assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety and Depression levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants that quit smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of surgical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Lower limb pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to symptom-free for fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intraoperative three-dimensional left ventricular ejection fraction (3-D LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Arms accuracy (breaths per minute)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhodes index for nausea and vomiting and retching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Modified pregnancy unique quantification of emesis and nausea (MPUQE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in rate of peer-directed communication acts
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: mean change in blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total wound closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in medial knee contact forces during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in lateral knee contact forces during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in patellofemoral knee contact forces during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Border Line Symptom list BSL 23
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of post-interventional internal jugular vein thrombi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety Evaluation of the Device
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy rate of transarterial CT angiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total effective dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Early hemoptysis recurrence rate
Endpoint domain: Adverse events/effects
Primary endpoint: Use of intervention responses with physician
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes from baseline in the Framing Challenging Behaviors Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline in Job Stress Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Language Environment Analysis (LENA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in CHILD for Home-Based Child Care Observation Tool
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from Baseline in Infant-Toddler Risk of Expulsion assessment
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from baseline in Devereux Early Childhood Assessment for Infants/Toddlers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neurobehavioral symptoms in children taking PEG 3350
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline neurobehavioral symptoms in children not taking PEG 3350
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence and severity of major bleeding according to anticoagulation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and severity of clinically Relevant Non-Major (CRNM) bleeding according to anticoagulation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: restenosis incidence of target lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of chemotherapy-induced diarrhea ≥ grade 1
Endpoint domain: Adverse events/effects
Primary endpoint: Gastro-intestinal biopotentials pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve in Breast Milk (AUC [0-∞])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in foot perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Late recurrence of atrial tachycardia/atrial fibrillation (AT/AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Choice accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning rate from a reinforcement learning model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34+ blast cells modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Gastric Antrum Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of abatacept
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of moderate to severe pain during movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of successful administrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of technical success procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain reward reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute reinforcement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of CDC-guideline based physical activity compliance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change from baseline in cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients with decreased aPL titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rhodes Index nausea, vomiting and Reaching Score (RINVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Simulator Sickness Questionnaire
Endpoint domain: Adverse events/effects
Primary endpoint: Game Experience Questionnaire (post game module)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mucositis score (WHO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mucositis score (NCI-CTCAE v3.0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral feeding (NCI-CTCAE v4.0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in Urticaria Activity Score (UAS7)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of lesions correlating 18F-FDHT uptake with IHC expression of AR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intention, Attitude and Behavior Scale in Gestational Diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Diabetes Self-Care Activities Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of Target Arean Hair Count (TAHC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean fold-change of metabolomics markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Highest pain score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Last pain score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Central retinal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK similarity by AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PK similarity by Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients able to discontinue immunosuppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Screening for esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of medical and social consultations one year after inclusion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of newcomer biological assessments prescribed by the doctor one year after inclusion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Homologous Recombination Deficiency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gene expression of cellular senescence marker p16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's Disease Questionnaire - 39 (PDQ-39)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Movement Disorders Society Unified Parkinson Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment rate of participants into the trial
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Compliance as measured by the self-reported volume of ketone supplement drink consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention as measured by the number of participants that complete the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients received Red blood cell transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: The area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Fog Severity Scale (BFSS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline score of the Facial Nerve Grading System 2.0
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Adenomas per Colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: POSAS score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Investigator Global Assessment of Performance (IGAP)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse Event incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Bronco Aerobic Fitness Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of slowed breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Plasma concentration of naloxone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in Fugl-Meyer Assessment (FMA) - upper limb section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Action Research Arm Test (ARAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder proprioception measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early detection of cirrhosis-associated signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: AF termination rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in hand discomfort scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of radioligands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCU admission
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of onset and/or staging of neurodegenerative and metabolic pathologies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Semi quantitative measurements of [68Ga]Ga-FAPI-46 tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood activity measurements of [68Ga]Ga-FAPI-46 tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Plasma to blood ratio of [68Ga]Ga-FAPI-46 tracer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of laboratory markers of cholestasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes of intestinal microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cough rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Optimization Potential Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in underarm odor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in clothing staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative nausea and vomiting intensity scale (6 hours)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (index)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of participants who experience COVID-19 related hospitalization or death
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients with ≥Grade 3 treatment related adverse event (TRAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Death or myocardial rupture at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Change in left ventricular ejection fraction from baseline to 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensory function assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of steatohepatitis and liver fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Blood Pressure Evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes